Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 89,849 shares at $9.01 ($779K) on 2021-05-03, disclosed to the SEC on 2021-05-05.
Open-market sale of $779k PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.01 | 8,765 | $79K | 10.1% |
| 2 | $9.01 | 8,765 | $79K | 10.1% |
| 3 | $9.01 | 9,561 | $86K | 11.1% |
| 4 | $9.01 | 9,561 | $86K | 11.1% |
| 5 | $8.44 | 17,211 | $145K | 18.6% |
| 6 | $8.44 | 17,211 |
| $145K |
| 18.6% |
| 7 | $8.44 | 18,775 | $158K | 20.3% |
| Total | $8.67 avg | 89,849 | $779K | 100% |
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |